Balance Sheet
Accounts PayablesAssetsCash & EquivalentsConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Current Assets: 2022-2024

Historic Current Assets for Abivax (ABVX) over the last 3 years, with Dec 2024 value amounting to $184.7 million.

  • Abivax's Current Assets fell 62.75% to $97.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $97.5 million, marking a year-over-year decrease of 62.75%. This contributed to the annual value of $184.7 million for FY2024, which is 40.28% down from last year.
  • As of FY2024, Abivax's Current Assets stood at $184.7 million, which was down 40.28% from $309.3 million recorded in FY2023.
  • In the past 5 years, Abivax's Current Assets registered a high of $309.3 million during FY2023, and its lowest value of $38.1 million during FY2022.
  • Moreover, its 3-year median value for Current Assets was $184.7 million (2024), whereas its average is $177.4 million.
  • Its Current Assets has fluctuated over the past 5 years, first soared by 711.21% in 2023, then crashed by 40.28% in 2024.
  • Abivax's Current Assets (Yearly) stood at $38.1 million in 2022, then spiked by 711.21% to $309.3 million in 2023, then tumbled by 40.28% to $184.7 million in 2024.